RTI Surgical Inc. (RTIX)

4.49
0.07 1.58
NASDAQ : Health Technology
Prev Close 4.42
Open 4.49
Day Low/High 4.44 / 4.62
52 Wk Low/High 3.85 / 5.10
Volume 134.30K
Avg Volume 112.70K
Exchange NASDAQ
Shares Outstanding 63.38M
Market Cap 280.13M
P/E Ratio 75.83
Div & Yield N.A. (N.A)

Latest News

Notable Two Hundred Day Moving Average Cross - RTIX

Notable Two Hundred Day Moving Average Cross - RTIX

In trading on Monday, shares of RTI Surgical, Inc. crossed below their 200 day moving average of $4.57, changing hands as low as $4.55 per share.

RTI Surgical Announces Second Quarter 2018 Results

RTI Surgical Announces Second Quarter 2018 Results

RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, reported operating results for the second quarter of 2018.

RTI Surgical® And Aziyo® Biologics Announce Exclusive Agreement To Distribute ViBone® For Spine And Other Orthopedic Procedures

RTI Surgical® And Aziyo® Biologics Announce Exclusive Agreement To Distribute ViBone® For Spine And Other Orthopedic Procedures

RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, and Aziyo Biologics, Inc.

Lions Eye Institute And RTI Donor Services Expand Strategic Relationship To Maximize The Gift Of Tissue Donation

Lions Eye Institute And RTI Donor Services Expand Strategic Relationship To Maximize The Gift Of Tissue Donation

The Lions Eye Institute for Transplant and Research (LEITR), a nonprofit organization dedicated to the recovery, evaluation and distribution of eye tissue, and RTI Donor Services, Inc.

BloodCenter Of Wisconsin And RTI Donor Services Expand Strategic Relationship To Maximize The Gift Of Tissue Donation

BloodCenter Of Wisconsin And RTI Donor Services Expand Strategic Relationship To Maximize The Gift Of Tissue Donation

BloodCenter of Wisconsin (BCW), part of the nonprofit organization Versiti, and RTI Donor Services, Inc.

RTI Surgical (RTIX) Shares Cross Below 200 DMA

RTI Surgical (RTIX) Shares Cross Below 200 DMA

In trading on Friday, shares of RTI Surgical, Inc. crossed below their 200 day moving average of $4.58, changing hands as low as $4.57 per share.

RTI Surgical® Schedules Second Quarter 2018 Earnings Call For August 2, 2018

RTI Surgical® Schedules Second Quarter 2018 Earnings Call For August 2, 2018

RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced that it plans to release financial results from the second quarter of 2018 on Thursday, August 2, 2018, prior to the market open.

RTIX Makes Notable Cross Below Critical Moving Average

RTIX Makes Notable Cross Below Critical Moving Average

In trading on Monday, shares of RTI Surgical, Inc. crossed below their 200 day moving average of $4.57, changing hands as low as $4.50 per share.

Zavation Medical Products Announces Brian K. Hutchison As Newest Member Of Its Board Of Directors

Zavation Medical Products Announces Brian K. Hutchison As Newest Member Of Its Board Of Directors

JACKSON, Miss., June 20, 2018 /PRNewswire/ -- Zavation Medical Products ("Zavation" or "the Company"), a LongueVue Capital Partners ("LVC") portfolio company that designs and manufacturers high-quality spinal implants, instruments, and biologics,...

Series Of Fortilink Interbody Fusion Devices Featuring TETRAfuse 3D Technology (From Top, Clockwise: Fortilink-C IBF System, Fortilink-TS IBF System, Fortilink-L IBF System)

Series Of Fortilink Interbody Fusion Devices Featuring TETRAfuse 3D Technology (From Top, Clockwise: Fortilink-C IBF System, Fortilink-TS IBF System, Fortilink-L IBF System)

RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, announced the full commercial launch of its Fortilink®-TS and -L IBF Systems, adding to a growing series of interbody fusion devices featuring proprietary TETRAfuse® 3D Technology.

RTI Surgical Announces First Quarter 2018 Results

RTI Surgical Announces First Quarter 2018 Results

RTI Surgical, Inc. (Nasdaq:RTIX), a global surgical implant company, reported operating results for the first quarter of 2018.

RTI Surgical Schedules First Quarter 2018 Earnings Call For May 3, 2018

RTI Surgical Schedules First Quarter 2018 Earnings Call For May 3, 2018

RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced that it plans to release financial results for the first quarter 2018 on Thursday, May 3, 2018 prior to the market open.

RTI Surgical Reaches Global Milestone Of Providing 8 Million Biologic Implants With Zero Confirmed Incidence Of Implant-Associated Infection

RTI Surgical Reaches Global Milestone Of Providing 8 Million Biologic Implants With Zero Confirmed Incidence Of Implant-Associated Infection

RTI Surgical, Inc. (Nasdaq: RTIX), a global provider of surgical implants, celebrates a significant global milestone of providing more than 8 million biologic implants processed through RTI's proprietary sterilization...

Data Showcasing Strength Of RTI's SImmetry® System In Sacroiliac Joint Fusion Published In The Spine Journal

Data Showcasing Strength Of RTI's SImmetry® System In Sacroiliac Joint Fusion Published In The Spine Journal

RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced data on the SImmetry® Sacroiliac Joint Fusion System have been published in The Spine Journal, the official journal of the North...

RTI Surgical Announces Fourth Quarter And Full Year 2017 Results

RTI Surgical Announces Fourth Quarter And Full Year 2017 Results

RTI Surgical, Inc. (Nasdaq:RTIX), a global surgical implant company, reported operating results for the fourth quarter and full year of 2017.

RTI Surgical® Schedules Fourth Quarter And Full Year 2017 Earnings Call For March 1, 2018

RTI Surgical® Schedules Fourth Quarter And Full Year 2017 Earnings Call For March 1, 2018

RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced that it plans to release financial results from the fourth quarter and full year of 2017 on Thursday, March 1, 2018 prior to the market...

Published Data Show Successful 24-Month Sacroiliac Joint Fusion And Pain Reduction With The SImmetry® System

Published Data Show Successful 24-Month Sacroiliac Joint Fusion And Pain Reduction With The SImmetry® System

RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced the peer-reviewed publication of two-year data of the SImmetry Sacroiliac Joint Fusion System in The Open Orthopaedics Journal.

RTI Surgical Outlines 2018 Guidance And Long-Term Goals

RTI Surgical Outlines 2018 Guidance And Long-Term Goals

RTI Surgical, Inc. (Nasdaq:RTIX), a global surgical implant company, today outlined its 2018 guidance and long-term financial goals.

RTI Surgical Announces Acquisition Of Zyga Technology, Inc.

RTI Surgical Announces Acquisition Of Zyga Technology, Inc.

RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, today signed an agreement to acquire Zyga Technology, Inc.

RTIX: Insiders vs. Shorts

RTIX: Insiders vs. Shorts

The most recent short interest data was recently released for the 11/30/2017 settlement date, and RTI Surgical, Inc. is one of the most shorted stocks of the Russell 3000, based on 7.31 "days to cover" versus the median component at 5.11.

RTI Surgical® Announces 2017 Third Quarter Results

RTI Surgical® Announces 2017 Third Quarter Results

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, reported operating results for the third quarter, ended September 30, 2017.

RTI Surgical® Schedules 2017 Third Quarter Earnings Call For November 2, 2017

RTI Surgical® Schedules 2017 Third Quarter Earnings Call For November 2, 2017

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, today announced that it plans to release financial results from the third quarter 2017 on Thursday, November 2, 2017 prior to the market open.

Fortilink-C IBF System (Photo: Business Wire)

Fortilink-C IBF System (Photo: Business Wire)

RTI Surgical, Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, today announced the commercial launch of Fortilink-C IBF System with TETRAfuse ® 3D Technology.

RTI Surgical® Introduces TETRAfuse® 3D Technology Becoming First To Offer 3D Printed Interbody Polymer Optimized To Participate In Fusion

RTI Surgical® Introduces TETRAfuse® 3D Technology Becoming First To Offer 3D Printed Interbody Polymer Optimized To Participate In Fusion

RTI Surgical, Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, today announced the introduction of TETRAfuse ® 3D Technology, providing surgeons a solution they have been seeking.

RTI Surgical® Continues To Augment Leadership Team To Accelerate Its Strategic Direction

RTI Surgical® Continues To Augment Leadership Team To Accelerate Its Strategic Direction

RTI Surgical Inc. (RTI) (Nasdaq:RTIX), a leading global surgical implant company, announced today three new appointments to its senior leadership team to accelerate the Company's strategic growth initiatives.

RTIX: Insiders Vs. Shorts

RTIX: Insiders Vs. Shorts

The most recent short interest data was recently released for the 08/31/2017 settlement date, and RTI Surgical, Inc. is one of the most shorted stocks of the Russell 3000, based on 9.03 "days to cover" versus the median component at 6.19.

RTI Surgical Becomes Oversold (RTIX)

RTI Surgical Becomes Oversold (RTIX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

RTI Surgical® Announces 2017 Second Quarter Results

RTI Surgical® Announces 2017 Second Quarter Results

RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, reported operating results for the second quarter of 2017.

TheStreet Quant Rating: C (Hold)